Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
12,216 patients undergoing operative treatment for extremity fractures or any pelvic or acetabular fractures were randomized to receive either low-molecular-weight heparin (30 mg enoxaparin) or 81 mg of aspirin, twice daily. The primary outcome of this trial was all-cause mortality by 90 days. Secondary outcomes of interest included cause-specific death, non-fatal pulmonary embolism, deep vein thr...